Shang Hai Zheng Quan Bao·2025-11-17 19:33Core Points - The chairman of Baolingbao Biotech Co., Ltd., Mr. Dai Jue, has resigned due to personal reasons, effective immediately upon submission of his resignation report [1][2] - Mr. Dai Jue will continue to serve as a director for the company's wholly-owned subsidiaries, BLB International Development (Singapore) PTE. LTD. and BLB Bio-Tech USA INC [1] - The resignation will not affect the minimum number of board members or the normal operation of the board and the company [2] Company Information - Mr. Dai Jue holds 29,508,653 shares of the company through Beijing Yongyu Investment Management Co., Ltd., representing 7.75% of the total share capital, and is one of the actual controllers of the company [2] - The board expressed gratitude for Mr. Dai Jue's contributions to the company's strategic development and stable operations during his tenure [2]